We are pleased to participate in the Asia Summit on Global Health (ASGH) 2026, where we presented our pioneering research on 4-end sequencing to a global audience of healthcare leaders, policy experts and academic pioneers.

Jointly organised by the HKSAR Government and the Hong Kong Trade Development Council (HKTDC), ASGH served as a premier platform for high-level exchange and international collaboration.  During the summit, we are honoured to receive an official delegation from the United Kingdom for in-depth discussions, while also engaging with potential industry partners during the deal-making sessions to explore commercial synergies.

We look forward to transforming the insights and connections gained at ASGH 2026 into impactful collaborations at the forefront of the healthcare industry.